NCT04017793

Brief Summary

The purpose of this study to measure brain functioning before and after stress-reduction classes to better understand how symptom improvements relate to brain functioning in adults with ASD (Autism Spectrum Disorder). Participants will be randomly assigned to one of two stress reduction classes that will meet once a week for 8 weeks. One group will complete a structured training program called Mindfulness Based Stress Reduction (MBSR) that involves teaching about increased mindfulness strategies and gentle stretching. The other group will review relaxation techniques and other stress reduction strategies and will include social support. Structural and functional MRI, EEG, and behavioral self-report data will be collected to understand more about how the brain changes in subtle ways when people feel better and are more aware of their emotional state.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 6, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 9, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 12, 2019

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 15, 2026

Status Verified

January 1, 2026

Enrollment Period

2.7 years

First QC Date

July 9, 2019

Last Update Submit

January 13, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Beck Depression Inventory - II

    21-question multiple-choice self-report inventory for measuring depression severity. Items are rated on a 4-point scale ranging from 0 to 3 based on severity of each item. The maximum total score is 63. Raw scores ranging from 0-13 indicate minimal depression. Raw scores ranging from 14-19 indicate mild depression. Raw scores of 20-28 indicate moderate depression and scores of 29-63 indicate severe depression.

    Baseline; Pre-intervention

  • Beck Depression Inventory - 2

    21-question multiple-choice self-report inventory for measuring depression severity. Items are rated on a 4-point scale ranging from 0 to 3 based on severity of each item. The maximum total score is 63. Raw scores ranging from 0-13 indicate minimal depression. Raw scores ranging from 14-19 indicate mild depression. Raw scores of 20-28 indicate moderate depression and scores of 29-63 indicate severe depression.

    Post-intervention (~10 weeks)

  • State-Trait Anxiety Inventory

    Self-report inventory measuring two types of anxiety. 20 items assess the temporary condition of state anxiety, or anxiety about an event, and an additional 20 items assess the more general trait anxiety, or anxiety level as a personal characteristic. Items are rated on a 4-point frequency scale. Scores range from 20 to 80, with higher scores correlating with greater anxiety.

    Baseline; Pre-intervention

  • State-Trait Anxiety Inventory

    Self-report inventory measuring two types of anxiety. 20 items assess the temporary condition of state anxiety, or anxiety about an event, and an additional 20 items assess the more general trait anxiety, or anxiety level as a personal characteristic. Items are rated on a 4-point frequency scale. Scores range from 20 to 80, with higher scores correlating with greater anxiety.

    Post-intervention (~10 weeks)

Secondary Outcomes (1)

  • World Health Organization Quality of Life

    Baseline; Pre-intervention and Post-intervention

Other Outcomes (6)

  • Blood-oxygen-level dependent (BOLD) response in brain regions activated during a self-reflection fMRI task

    Baseline; Pre-intervention

  • Blood-oxygen-level dependent (BOLD) response in brain regions activated during a self-reflection fMRI task

    Post-intervention (~10 weeks)

  • Blood-oxygen-level dependent (BOLD) response in regions activated during an emotion-regulation fMRI task

    Baseline; Pre-intervention

  • +3 more other outcomes

Study Arms (2)

Mindfulness Based Stress Reduction Program

ACTIVE COMPARATOR
Behavioral: Mindfulness Based Stress Reduction

Relaxation Group

ACTIVE COMPARATOR
Behavioral: Relaxation Group

Interventions

8-weekly group discussion meetings reviewing relaxation techniques and other stress reduction strategies with an emphasis on social support.

Relaxation Group

Structured 8-week training program teaching about increased mindfulness strategies and gentle stretching.

Mindfulness Based Stress Reduction Program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 to 89 years old, with a special focus on adults with ASD who are going to college given the additional stress of this phase in life. We are recruiting participants across a broad age range in order to maximize our ability to inform interventions for adults with ASD. The upper age limit of 89 years was selected so a de-identified dataset can be created with all participant ages included.
  • ASD diagnosis via gold-standard diagnostic assessments (Autism Diagnostic Observation Schedule-2).
  • Must be able to attend at least 7 of the 8 weekly intervention classes.
  • English speaking: Participants must be English-speaking because the screening and behavioral measures are in English (including the intelligence estimate).

You may not qualify if:

  • Participants with Intelligence Quotient (IQ) scores \<70 will be excluded to minimize variability due to general cognitive functioning.
  • Report of any major medical illnesses, histories of seizures, or head trauma with loss of consciousness. These health factors can cause brain changes that would confound findings.
  • Concerns that the participant may not be able to complete the MRI neuroimaging requirements for the study, including claustrophobia or metal objects within the participant's body or eyes. Implanted metal objects may create a safety hazard in the powerful magnetic field during MRI imaging.
  • Pregnant women. MRI has no known effects on pregnancy or fertility. However, since we are not 100% certain MRI has no effects on a developing fetus, women who are pregnant may not participate in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arizona State University

Tempe, Arizona, 85281, United States

Location

Related Publications (2)

  • Pagni BA, Hill E, Walsh MJM, Delaney S, Ogbeama D, Monahan L, Cook JR, Guerithault N, Dixon MV, Ballard L, Braden BB. Distinct and shared therapeutic neural mechanisms of mindfulness-based and social support stress reduction groups in adults with autism spectrum disorder. J Psychiatry Neurosci. 2023 Mar 29;48(2):E102-E114. doi: 10.1503/jpn.220159. Print 2023 Mar-Apr.

  • Braden BB, Pagni BA, Monahan L, Walsh MJM, Dixon MV, Delaney S, Ballard L, Ware JE Jr. Quality of life in adults with autism spectrum disorder: influence of age, sex, and a controlled, randomized mindfulness-based stress reduction pilot intervention. Qual Life Res. 2022 May;31(5):1427-1440. doi: 10.1007/s11136-021-03013-x. Epub 2021 Oct 16.

MeSH Terms

Conditions

Autism Spectrum Disorder

Interventions

Mindfulness-Based Stress Reduction

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Brittany B Braden, PhD

    Assistant Professor; Autism and Brain Aging Laboratory Director

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor; Autism and Brain Aging Laboratory Director

Study Record Dates

First Submitted

July 9, 2019

First Posted

July 12, 2019

Study Start

May 6, 2019

Primary Completion

December 31, 2021

Study Completion

December 31, 2024

Last Updated

January 15, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

All individual participant data (IPD) that underlie results in a publication will be available upon request to approved researchers.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Data will be available upon request starting 6 months after publication and will remain available for 2 years.
Access Criteria
Data requests should be submitted to Dr. Braden at bbbraden@asu.edu and must include study aims and purpose and a detailed analysis plan describing how the data will be used. Requests will be reviewed by Dr. Braden and access to the data will be made available through a secure link to download the requested data.

Locations